LONG INV CORP (02312) net asset value per share at the end of August was approximately HK$0.31.
LONG INV CORP (02312) announced that as of August 31, 2026, the unaudited net asset value per share of LONG INV CORP (the Company) and its subsidiaries was approximately HK$0.31.
LONG INV CORP (02312) announced that as of August 31, 2026, the unaudited net asset value per share of LONG Investment Group (the Company) and its subsidiaries was approximately HK$0.31.
Related Articles
Citi: Raises PRADA (01913) target price to HK$41.5, maintains "Neutral" rating.
Shenyang Xingqi Pharmaceutical (300573.SZ): SQ-25012 Injection Receives Clinical Trial Approval Notice
Hebei Changshan Biochemical Pharmaceutical (300255.SZ): Heparin Sodium Injection obtains Moldova drug registration certificate.
Citi: Raises PRADA (01913) target price to HK$41.5, maintains "Neutral" rating.
Shenyang Xingqi Pharmaceutical (300573.SZ): SQ-25012 Injection Receives Clinical Trial Approval Notice
Hebei Changshan Biochemical Pharmaceutical (300255.SZ): Heparin Sodium Injection obtains Moldova drug registration certificate.
RECOMMEND
